Please login to the form below

Not currently logged in
Email:
Password:

tobramycin

This page shows the latest tobramycin news and features for those working in and with pharma, biotech and healthcare.

Sandoz admits antitrust crime, pays $195m in penalties

Sandoz admits antitrust crime, pays $195m in penalties

nystatin/triamcinolone and tobramycin inhalation solution.

Latest news

  • CURx buys rights to Gilead’s lung infection drug CURx buys rights to Gilead’s lung infection drug

    Agrees deal for fosfomycin/tobramycin combination. CURx Pharmaceuticals has acquired the rights to Gilead Sciences' investigational drug for a lung infection associated with cystic fibrosis. ... Dinu Sen, CEO and founder of CURx, said that

  • NICE backs Novartis/ ThromboGenics’ eye drug NICE backs Novartis/ ThromboGenics’ eye drug

    ranibizumab). Novartis has also won the cost-effectiveness watchdog's backing in 2013 for the Tobi Podhaler (tobramycin), a treatment for cystic fibrosis.

  • NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest NICE gives final ‘yes’ to cystic fibrosis drugs from Novartis and Forest

    Both the Tobi Podhaler (tobramycin) from Novartis and Colobreathe (colistimethate sodium) received backing to treat people with cystic fibrosis who have chronic pulmonary infection caused by Pseudomonas aeruginosa in final guidance ... form. The Tobi

  • NICE backs two cystic fibrosis treatments for NHS use NICE backs two cystic fibrosis treatments for NHS use

    Novartis' Tobi Podhaler is a dry powder version of tobramycin, which is also already available in a nebulised form that is recommended for patients unable to take nebulised colistimethate sodium as ... The recommendation is also limited, however, and the

  • Breathing easier

    Silenor (Somaxon Pharmaceuticals). Sleep maintenance insomnia. US. Tobramycin/dexamethasone. TobraDex ST (Alcon).

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

brian smith science of the deal
The science of the deal
Business development is more like child-raising than you might think...
The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...

Infographics